Healthcare provider profile · identity verified

Judith Allen, M.D.

Internal Medicine · ROCHESTER, NY · NPI 1851320212

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	968	228
Atorvastatin Calcium	Atorvastatin Calcium	623	191
Amlodipine Besylate	Amlodipine Besylate	494	131
Zolpidem Tartrate	Zolpidem Tartrate	451	58
Pantoprazole Sodium	Pantoprazole Sodium	392	110
Gabapentin	Gabapentin	379	92
Rosuvastatin Calcium	Rosuvastatin Calcium	333	105
Omeprazole	Omeprazole	328	95
Lisinopril	Lisinopril	301	87
Bupropion Xl	Bupropion Hcl	268	67
Metoprolol Succinate	Metoprolol Succinate	258	61
Meloxicam	Meloxicam	253	76
Alprazolam	Alprazolam	217	62
Sertraline Hcl	Sertraline Hcl	213	57
Ozempic	Semaglutide	187	25
Hydrochlorothiazide	Hydrochlorothiazide	185	56
Citalopram Hbr	Citalopram Hydrobromide	184	47
Simvastatin	Simvastatin	181	56
Duloxetine Hcl	Duloxetine Hcl	155	32
Fluoxetine Hcl	Fluoxetine Hcl	155	34
Metformin Hcl Er	Metformin Hcl	148	44
Famotidine	Famotidine	140	51
Metformin Hcl	Metformin Hcl	137	38
Doxepin Hcl	Doxepin Hcl	136	39
Fluticasone Propionate	Fluticasone Propionate	121	28
Irbesartan	Irbesartan	120	30
Trazodone Hcl	Trazodone Hcl	114	33
Eliquis	Apixaban	113	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	36
Tramadol Hcl	Tramadol Hcl	109	29
Atenolol	Atenolol	105	37
Tizanidine Hcl	Tizanidine Hcl	99	33
Escitalopram Oxalate	Escitalopram Oxalate	97	30
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	95	30
Celecoxib	Celecoxib	95	30
Potassium Chloride	Potassium Chloride	95	22
Olmesartan Medoxomil	Olmesartan Medoxomil	94	25
Albuterol Sulfate Hfa	Albuterol Sulfate	88	34
Carvedilol	Carvedilol	87	22
Montelukast Sodium	Montelukast Sodium	87	23
Oxycodone Hcl	Oxycodone Hcl	87	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	86	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	20
Synthroid	Levothyroxine Sodium	83	22
Quetiapine Fumarate	Quetiapine Fumarate	81	14
Valacyclovir	Valacyclovir Hcl	80	22
Indapamide	Indapamide	78	21
Prednisone	Prednisone	75	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	68	22
Allopurinol	Allopurinol	67	17
Estradiol	Estradiol	67	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	66	15
Metoprolol Tartrate	Metoprolol Tartrate	64	16
Lansoprazole	Lansoprazole	60	20
Januvia	Sitagliptin Phosphate	56	11
Flurbiprofen	Flurbiprofen	55	13
Mirtazapine	Mirtazapine	55	12
Alendronate Sodium	Alendronate Sodium	54	12
Glimepiride	Glimepiride	53	17
Jardiance	Empagliflozin	52	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	18
Sumatriptan Succinate	Sumatriptan Succinate	50	11
Baclofen	Baclofen	49	23
Tamsulosin Hcl	Tamsulosin Hcl	49	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	47	13
Hydroxyzine Hcl	Hydroxyzine Hcl	47	17
Venlafaxine Hcl Er	Venlafaxine Hcl	47	15
Raloxifene Hcl	Raloxifene Hcl	44	11
Azithromycin	Azithromycin	43	30
Losartan Potassium	Losartan Potassium	43	16
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	21
Doxycycline Hyclate	Doxycycline Hyclate	41	31
Dicyclomine Hcl	Dicyclomine Hcl	40	suppressed
Fluconazole	Fluconazole	39	26
Torsemide	Torsemide	39	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	38	11
Buspirone Hcl	Buspirone Hcl	37	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	37	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	37	suppressed
Spironolactone	Spironolactone	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	32
Clonazepam	Clonazepam	36	suppressed
Furosemide	Furosemide	36	11
Methylprednisolone	Methylprednisolone	36	30
Nortriptyline Hcl	Nortriptyline Hcl	36	suppressed
Lorazepam	Lorazepam	35	suppressed
Xarelto	Rivaroxaban	33	suppressed
Fentanyl	Fentanyl	32	suppressed
Nystatin	Nystatin	31	suppressed
Topiramate	Topiramate	31	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	30	suppressed
Ibuprofen	Ibuprofen	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	12
Diclofenac Sodium	Diclofenac Sodium	29	18
Meclizine Hcl	Meclizine Hcl	29	18
Temazepam	Temazepam	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Amoxicillin	Amoxicillin	28	16
Cephalexin	Cephalexin	28	18
Lovastatin	Lovastatin	28	suppressed
Eszopiclone	Eszopiclone	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	11
Methimazole	Methimazole	26	suppressed
Felodipine Er	Felodipine	25	suppressed
Mometasone Furoate	Mometasone Furoate	25	12
Pregabalin	Pregabalin	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Telmisartan	Telmisartan	24	suppressed
Tramadol Hcl Er	Tramadol Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Trospium Chloride	Trospium Chloride	23	suppressed
Trospium Chloride Er	Trospium Chloride	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Glipizide	Glipizide	22	suppressed
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Diazepam	Diazepam	17	12
Ezetimibe	Ezetimibe	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Epinephrine	Epinephrine	15	12
Farxiga	Dapagliflozin Propanediol	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Imipramine Hcl	Imipramine Hcl	14	suppressed
Invokana	Canagliflozin	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	12	suppressed
Valsartan	Valsartan	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error